CYTRX CORP 4
4 · CYTRX CORP · Filed Dec 17, 2014
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option (right to buy)
2014-12-15+200,000→ 200,000 totalExercise: $2.15Exp: 2024-12-14→ CytRx common stock (200,000 underlying)
Footnotes (1)
- [F1]The Stock Option vests monthly for 36 months in equal installments, beginning January 15, 2015, provided Reporting Person remains in continuous employ of Issuer.